Pharmaids Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.50",
    "chg": -1.39,
    "chgp": "-4.36%",
    "dir": -1,
    "prev_price": "31.89",
    "mcapval": "111.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE117D01018",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": "23.29 k",
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Pharmaids Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2905-3919635",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_priceRelatedfactors_3919635.png",
        "date": "2026-03-27 12:47:12",
        "description": ""
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3917905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3917905.png",
        "date": "2026-03-26 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3888508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3888508.png",
        "date": "2026-03-13 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3864244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3864244.png",
        "date": "2026-03-02 10:10:21",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-amidst-continued-weakness-3858293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3858293.png",
        "date": "2026-02-26 14:37:27",
        "description": "Pharmaids Pharmaceuticals Ltd’s shares declined sharply to a new 52-week low of Rs.30 today, marking a significant drop amid a challenging market environment. The stock underperformed its sector and broader indices, reflecting ongoing concerns about the company’s financial health and market position."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.30.56",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs3056-3848403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3848403.png",
        "date": "2026-02-20 11:02:05",
        "description": "Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.30.56, marking a significant decline in its stock price amid broader market gains. The stock underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial and operational metrics."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.34",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs34-3847363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3847363.png",
        "date": "2026-02-19 15:39:25",
        "description": "Pharmaids Pharmaceuticals Ltd has touched a new 52-week low of Rs.34 today, marking a significant decline in its stock price amid broader market volatility and company-specific performance concerns. This level represents a sharp drop from its 52-week high of Rs.75.98, reflecting a year-long downward trajectory for the pharmaceutical firm."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3846798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_mojoScore_3846798.png",
        "date": "2026-02-19 10:10:26",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3845991",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PharmaidsPharma_priceRelatedfactors_3845991.png",
        "date": "2026-02-18 15:47:11",
        "description": "Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.34.5 today, marking a significant decline amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning."
      }
    ],
    "total": 112,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Receipt Of Accreditation By The American Association For Laboratory Accreditation (A2LA) For Testing Of Medical Devices In Biological Field.",
      "datetime": "24-Feb-2026",
      "details": "Intimation under Regulation 30 of LODR.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Feb-2026",
      "details": "Corrigendum to the newspaper publication dated February 14 2026 regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Markets Rally, But Pharmaids Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-27 12:47:12

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-26 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-13 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-02 10:10:21

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low Amidst Continued Weakness

2026-02-26 14:37:27

Pharmaids Pharmaceuticals Ltd’s shares declined sharply to a new 52-week low of Rs.30 today, marking a significant drop amid a challenging market environment. The stock underperformed its sector and broader indices, reflecting ongoing concerns about the company’s financial health and market position.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.30.56

2026-02-20 11:02:05

Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.30.56, marking a significant decline in its stock price amid broader market gains. The stock underperformed its sector and continues to trade below all key moving averages, reflecting ongoing pressures within the company’s financial and operational metrics.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs.34

2026-02-19 15:39:25

Pharmaids Pharmaceuticals Ltd has touched a new 52-week low of Rs.34 today, marking a significant decline in its stock price amid broader market volatility and company-specific performance concerns. This level represents a sharp drop from its 52-week high of Rs.75.98, reflecting a year-long downward trajectory for the pharmaceutical firm.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-02-19 10:10:26

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Pharmaids Pharmaceuticals Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-02-18 15:47:11

Pharmaids Pharmaceuticals Ltd has reached a new 52-week low of Rs.34.5 today, marking a significant decline amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning.

Read full news article

View All News